WHO WE ARE
For more than 50 years, Nucro-Technics has been a leading Contract Support Organization for the pharmaceutical, biotech, medical device, and marijuana industries.
WHAT WE DO
Nucro-Technics conducts GMP & GLP-Compliant Chemistry, Microbiology, Toxicology, Genetic Toxicology, and Bioanalytical Testing to fulfill FDA, Health Canada, and European requirements.
HOW WE CAN HELP
▪ GMP Release Testing
▪ GLP IND-Enabling Studies
▪ Medical Device Testing
▪ Marijuana Testing & Profiling
▪ QA & Regulatory Affairs Consulting
LOOKING TO MEET GMP AND GLP TESTING REQUIREMENTS?
More Than Just a Testing Lab, Nucro-Technics Is Your Contract Testing Laboratory R&D Partner
Nucro-Technics is Canada’s largest privately-owned Contract Research / Contract Support Organization, routinely completing projects for 40 of the 50 biggest pharmaceutical, biotech, and medical device companies worldwide. With a client base that spans from virtual companies at the Investigation New Drug-enabling stage to multinational conglomerates requiring finished product release testing, Nucro-Technics supports all phases of pharmaceutical development. Accredited by Health Canada, the FDA, the Standards Council of Canada, and ISO-certified to the 9001: 2015 standard, Nucro-Technics has decades of experience across many therapeutic indications.
COMMON SERVICES OFFERED BY APPLICATION
GMP Finished Product Testing
GLP IND-Enabling Studies
Marijuana Testing
Clinical Trial Support
Proteomics
Stability Studies
News / Updates
Nitrosamine Impurities Testing With the Updated FDA Guidance
Nitrosamine impurities have recently become a very important topic in the world of pharmaceuticals. Ever since unacceptable levels of this probable carcinogen were detected in common drugs (including angiotension II receptor blockers, Zantac, metformin), [...]
Nucro-Technics’ COVID-19 Pandemic Response
The COVID-19 pandemic is serious and affects us all. Nucro-Technics is a business that has been deemed an essential service. Put simply, as part of our routine activities, the testing that we do allows for [...]
Nitrosamine Testing of Impurities
Health Canada recently sent a letter to Market Authorization Holders (MAHs) about nitrosamine testing of impurities in human pharmaceutical products. Nitrosamine are genotoxic compounds that are potentially carcinogenic even at low exposure levels. What [...]
NDMA Testing in Ranitidine / Zantac
Over the past week or so, drugs containing Ranitidine have been in the news with provocative headlines like: Drugmaker halts shipments of ranitidine heartburn medication Novartis halts distribution of Zantac drug amid probe into [...]